Potential persons who are to respond to the collection of
information contained in this form are not required to respond
unless the form displays a currently valid OMB control number.
--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest reported),
May 19, 2000
ASTHMA DISEASE MANAGEMENT, INC.
------------------------------------------------------
(Exact name of registrant as specified in its chapter)
DELAWARE 33-1534-D 22-3253496
---------------------------- ------------ ---------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification)
272 South White Horse Pike, Berlin, NJ 08009
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 800-448-8199
------------
Former name or former address, if changed since last report
-----------------------------------------------------------
N/A
<PAGE>
Pursuant to Item #4, "Change in Registrant's Certifying Accountant".
A "letter of engagement" has been signed by the registrant with the Accounting
firms of HJ & ASSOCIATES, (a McGlard Gladry Pullen company), located in Salt
Lake City, Utah, on July 11, 2000, and Ciro E. Adams, CPA located in Mantua, New
Jersey on July 7, 2000.
Pursuant to Item #5, "Other Events".
The Board of Directors of the Registrant has been changed effective May 19th,
2000, as follows;
Richard Anderson, DBA, Chairman
A.J. Henley, Director and President/CEO
Paul Dandridge, Director
Raymond H. Miley, III, Director
James O'Connor, Director
The Board of Directors appointed Albert S. Dandridge III, of the Law Firm of
MesirovGelman, Philadelphia, PA, as its General Legal Council.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ASTHMA DISEASE MANAGEMENT, INC.
/s/ A.J. Henley
-------------------------------
A.J. Henley, President/CEO
Date: July 11, 2000
2
